Related references
Note: Only part of the references are listed.Differentiation of Hodgkin lymphoma cells by reactive oxygen species and regulation by heme oxygenase-1 through HIF-1α
Makoto Nakashima et al.
CANCER SCIENCE (2021)
Transient genomic instability drives tumorigenesis through accelerated clonal evolution
Ofer Shoshani et al.
GENES & DEVELOPMENT (2021)
DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons
Therese Wilhelm et al.
GENES (2020)
ROS scavenger, N-acetyl-l-cysteine and NOX specific inhibitor, VAS2870 reduce platelets apoptosis while enhancing their viability during storage
Ehteramolsadat Hosseini et al.
TRANSFUSION (2019)
Hodgkin lymphoma cell lines: to separate the wheat from the chaff
Hans G. Drexler et al.
BIOLOGICAL CHEMISTRY (2018)
Trogocytosis of ligand-receptor complex and its intracellular transport in CD30 signalling
Makoto Nakashima et al.
BIOLOGY OF THE CELL (2018)
CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1-Infected Individuals
Makoto Nakashima et al.
CLINICAL CANCER RESEARCH (2018)
Establishment and characterization of a novel Hodgkin lymphoma cell line, AM-HLH, carrying the Epstein-Barr virus genome integrated into the host chromosome
Masahiko Hayashida et al.
HEMATOLOGICAL ONCOLOGY (2017)
Replication Stress in Mammalian Cells and Its Consequences for Mitosis
Camille Gelot et al.
GENES (2015)
Aurora B kinase in Hodgkin lymphoma: immunohistochemical pattern of expression in neoplastic Hodgkin and Reed-Sternberg cells
M. Ioannou et al.
JOURNAL OF MOLECULAR HISTOLOGY (2014)
Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells
Benjamin Rengstl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Combinatorics of the Breakage-Fusion-Bridge Mechanism
Marcus Kinsella et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2012)
Targeted Repression of Overexpressed CD30 Downregulates NF-κB and ERK1/2 Pathway in Hodgkin Lymphoma Cell Lines
Mariko Watanabe et al.
ONCOLOGY RESEARCH (2011)
The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma
Makoto Nakashima et al.
CANCER SCIENCE (2010)
Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles
Amanda Guffei et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
A Last-Minute Rescue of Trapped Chromatin
Chun-Ting Chen et al.
CELL (2009)
CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells
Burkhard Hirsch et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
CD30 activates both the canonical and alternative NF-κB pathways in anaplastic large cell lymphoma cells
Casey W. Wright et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival
B Zheng et al.
BLOOD (2003)
Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?
JI Martin-Subero et al.
LEUKEMIA (2003)
Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin-Reed-Sternberg cells
R Horie et al.
ONCOGENE (2002)
Reactive oxygen species are downstream products of TRAF-mediated signal transduction
NS Chandel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cell fusion is not involved in the generation of giant cells in the Hodgkin-Reed Sternberg cell line L1236
D Re et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Share Paper
